[HTML][HTML] A systematic approach to the development of cilostazol nanosuspension by liquid antisolvent precipitation (LASP) and its combination with ultrasound

E Jakubowska, B Milanowski, J Lulek - International Journal of Molecular …, 2021 - mdpi.com
Nanosizing is an approach to improve the dissolution rate of poorly soluble drugs. The first
aim of this work was to develop nanosuspension of cilostazol with liquid antisolvent …

Physical and dissolution characterization of cilostazol solid dispersions prepared by hot melt granulation (HMG) and thermal adhesion granulation (TAG) methods

YC Chen, HO Ho, JD Chiou, MT Sheu - International journal of …, 2014 - Elsevier
A growing number of poorly water-soluble drug have been discovered, but the poor
bioavailability is a critical problem. In this study, physical properties and dissolution profiles …

Contact line crystallization to obtain metastable polymorphs

JS Capes, RE Cameron - Crystal growth & design, 2007 - ACS Publications
Crystallization of the metastable polymorph of paracetamol has been shown to occur around
the edge of an evaporating aqueous solution. Conditions at the edge of a meniscus during …

Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol

X Miao, C Sun, T Jiang, L Zheng… - … of Pharmacy & …, 2011 - journals.library.ualberta.ca
Purpose: The aim of this study was to develop cilostazol (CLT) nanocrystals intended to
improve its dissolution rate and enhance its bioavailability. Methods: In this study, CLT …

Enhancement of wettability and dissolution properties of cilostazol using the supercritical antisolvent process: effect of various additives

MS Kim, JS Kim, SJ Hwang - Chemical and Pharmaceutical Bulletin, 2010 - jstage.jst.go.jp
The aim of this study was to improve wettability and dissolution rate of a poorly water-soluble
drug, cilostazol, using the supercritical antisolvent (SAS) process. The solid state of particles …

Can crystal engineering be as beneficial as micronisation and overcome its pitfalls?: A case study with cilostazol

KS Gouthami, D Kumar, R Thipparaboina… - International journal of …, 2015 - Elsevier
Improvement in dissolution of the drugs having poor solubility is a challenge in
pharmaceutical industry. Micronization is one technique, employed for dissolution …

[HTML][HTML] Comparative study of different crystallization methods in the case of cilostazol crystal habit optimization

T Tari, P Szabó-Révész, Z Aigner - Crystals, 2019 - mdpi.com
The therapeutic usage of cilostazol is limited owing to its poor aqueous solubility and oral
bioavailability. Our aim was to produce cilostazol crystals with small average particle size; …

3. Preparation and Identification of Polymorphs and Solvatomorphs

HG Brittain - Preformulation in solid dosage form development, 2008 - taylorfrancis.com
It is now very well known that the majority of organic compounds are capable of being
crystallized into more than one structural form (1-11). Polymorphism is defined as the …

Polymorphism of spironolactone: An unprecedented case of monotropy turning to enantiotropy with a huge difference in the melting temperatures

IB Rietveld, M Barrio, P Lloveras, R Céolin… - International journal of …, 2018 - Elsevier
Spironolactone form I melts at about 70 degrees lower than form II, which is very unusual for
two co-existing polymorphs. The phase relationships involving this unprecedented case of …

Fine Dosage of Antisolvent in the Crystallization of l-Histidine: Effect on Polymorphism

GD Profio, A Caridi, R Caliandro… - Crystal growth & …, 2010 - ACS Publications
In this work, the antisolvent membrane crystallization process has been used to influence
the polymorphic composition in the crystallization of l-histidine. When finely dosing the …